graft injury, we examined the hypothesis that the Introduction C677T variant of the methylenetetrahydrofolate reductase (MTHFR) gene, which is linked to elevated plasma Chronic allograft rejection, characterized by progresshomocysteine levels in patients with renal failure, deterive loss of function and sclerotic vascular lesions in mines renal allograft survival.
the transplant biopsy, is the most important determinMethods. DNA was prospectively collected from 336 ant of long-term kidney transplant survival [1, 2] . patients undergoing renal transplantation in our clinic Furthermore, cardiovascular morbidity in renalbetween 1988 and 1994 and their corresponding allograft recipients is high and remains the leading donors. Patient and allograft survival was analysed by cause of premature mortality in these patients [3, 4] . It blinded review of all case records over a follow-up has been known for nearly two decades that homocystperiod of 36 months. Additionally, we recruited 83 eine (Hcy), a small sulphur-containing amino acid, is patients surviving with a functional kidney allograft markedly elevated in patients on maintenance haemofor at least 10 years (mean: 156, range 120-240 dialysis [5] and in renal transplant recipients [6 ] .
months). MTHFR-C677T genotype was determined by
Recently, hyperhomocysteinaemia has been implicated a PCR-RFLP technique. The influence of genotype on as an independent risk factor for the development of transplant survival was analysed by Kaplan-Meyer atherosclerotic lesions both in patients with normal life-table analysis and two-tailed global log-rank [7, 8] The aim of the present study was therefore to data. Wherever there was any ambiguity, the PCR reaction, examine the relationship between the MTHFR-C677T
Hinf I digestion, and scoring were repeated.
genotype and renal allograft survival in kidney transplant recipients. As MTHFR is highly expressed in the Statistical analysis kidney [19] , and impairment of intra-renal Hcy metabolism may contribute to the development of hyperIn the cohort study, the relationship between MTHFR homocysteinaemia, we also studied the effect of genotype and allograft survival was examined using the donor MTHFR-C677T genotype on transplant Kaplan genotype ( Figure 1 ). Risk factors influencing graft survival (hypertension, recipient and donor age, bodyGenotyping mass index, and number of rejection therapies) were likewise similar between the genotype groups ( Table 1) .
MTHFR genotype was determined as previously described [22] . In brief, recipient and donor DNA was extracted from peripheral leukocytes by a selective preparation method Long-term survivors (Quiagen, Hilden, Germany). Reagent concentrations in the 10 ml PCR reaction were 600 nmol/l each for sense (5∞-CAA Genotype distribution in long-term renal allograft sur-AGG CCA CCC CGA AGC-3∞) and reverse (5∞-AGG ACG GTG CGG TGA GAG TG-3∞) primers, 200 mmol/l deoxy-vivors with an average graft survival of 156 months (range 120-240) (CC=30, CT=44, TT=9, qT=0.37) a risk factor for the development of end-stage kidney disease. was similar to that in the control group who had an The rationale for studying the relationship between allograft survival of less than 36 months (CC=43, the MTHFR-C677T genotype and renal allograft CT=54, TT=11, qT=0.35), and comparable both to survival was provided by the following: (i) nonthe donor and recipient genotype distribution in the immunological factors are believed to play an importcohort study.
ant role in the development and progression of chronic allograft injury [2, 23] .
(ii) The histopathological changes in chronic transplant rejection are character-
Discussion
ized by wall thickening of small arterial vessels due to smooth muscle proliferation and increased synthesis of Our results clearly show that the MTHFR-C677T extracellular matrix [13, 24] , changes that could be variant encoding for a thermolabile isoform of this accelerated by Hcy which is known to have a dose enzyme is not a clinically important determinant of dependent effect on vascular smooth muscle cell prolifshort or long-term renal allograft survival. Thus life-eration in vitro brought about by induction of cyclin table analysis revealed a similar transplant survival synthesis [25] . (iii) Hyperhomocysteinaemia is a wellover the 36-month follow-up period regardless of established risk factor to the development of atherodonor or recipient genotype. Furthermore the virtually sclerotic lesions in a variety of vascular beds both in identical frequency of the T allele in long-term sur-patients with normal [7, 8, 26 ] and impaired renal funcvivors suggests that this variant is not an important tion [9,10]. Finally, (iv) plasma total homocysteine predictor of long-term allograft or patient survival in levels are known to be elevated in patients with renal patients undergoing renal transplantation for end-stage failure [5, 27] and are in part, determined by the renal failure. The similar distribution of the MTHFR-MTHFR-C677T genotype [17]. Our findings, however, C677T genotype in donors and recipients, and the fact do not support this line of reasoning and do not that this distribution was similar to that previously provide evidence for a role of this genetic variant of reported in healthy Caucasian controls [14] , also dem-the MTHFR gene as a marker of renal allograft survival. onstrates that the presence of the TT genotype is not risk factor for vascular disease. N Engl J Med 1991; 324:
It is, however, important to note that the lack of a [1149] [1150] [1151] [1152] [1153] [1154] [1155] relationship between the MTHFR-C677T genotype and 
